Yuyang Zhou

Margaret Kosal

Margaret E. Kosal is Professor (as of August 2025) of International Affairs at the Georgia Institute of Technology. Her research uses theories and concepts from the social sciences, primarily international relations, to explore relationships among science, technology, and security and to explain how these phenomena impact geopolitics and how geopolitics affects innovation. She focuses on two, often intersecting, areas: understanding the politics of emerging technologies and reducing the threat of weapons of mass destruction (WMD). She holds appointments as affiliated faculty in the Parker H. Petit Institute for Bioengineering and Bioscience and the Georgia Tech Institute for Matter and Systems (IMS). Formally trained as an experimental scientist, Kosal earned a doctoral degree in Chemistry from the University of Illinois at Urbana-Champaign (UIUC) working on biomimetic and nano-structured functional materials.
Kosal has served as a Senior Advisor to the Chief of Staff of the U.S. Army, as Science and Technology Advisor within the Office of the Secretary of Defense (OSD), and as an Associate to the National Intelligence Council (NIC). She earned a Ph.D. in chemistry from the University of Illinois at Urbana-Champaign (UIUC) and a B.S. in chemistry from the University of Southern California. She is also the co-founder of a sensor company, where she led research and development of medical, biological, chemical sensors and explosives detection. In January 2017, Kosal was appointed the Editor-in-Chief of the Cambridge University Press journal, “Politics and the Life Sciences.’ Her honors include being elected an Honorary Lifetime Fellow of the American Association for the Advancement of Science (AAAS). She is a champion of students as young scholars at the intersection of science, technology, and international affairs, and she is committed to bridging the academic-policy gap, as seen by her leadership on national and international advisory boards and committees.

Edward Kalkreuter

Edward Kalkreuter started as an Assistant Professor in Chemistry & Biochemistry at Florida State University in 2024. He received his BS in Chemistry at Emory University and his PhD in Chemistry from North Carolina State University under Gavin Williams (engineering polyketide synthases and genetic biosensors). He then conducted his NIH postdoctoral fellowship under Ben Shen at Scripps Research, where he studied microbial natural product discovery, biosynthesis, and synthetic biology. His research group currently is focused on leveraging and developing synthetic biology techniques and strategies for the discovery of novel natural products and their chemistries.

Taylor Nichols

Taylor is an accomplished scientist and engineer with over a decade of experience across academia and industry developing strategic research initiatives, managing collaborative projects, and driving technical project management. As the Director of Research for Northwestern University’s Center for Synthetic Biology (CSB), her responsibilities include working with CSB leadership, faculty, and staff to help grow the research capacity of the Center and provide strategic direction for new research endeavors and partnerships. She also contributes to long-term planning in support of the Center’s education, research, and outreach missions. Taylor holds a PhD in Chemical and Biological Engineering from Northwestern University where she worked in the lab of Danielle Tullman-Ercek. Her dissertation research focused on engineering bacterial microcompartments (MCPs) for the encapsulation of non-native metabolic pathways, notably developing a genomic integration platform to control cargo encapsulation in MCPs. She earned her Bachelor of Science in Chemical Engineering with a minor in Biochemical Engineering at Northeastern University.

Lauren Rajakovich

Lauren received her B.S. in Chemistry from Wake Forest University in 2011, working in the laboratory of Patricia Dos Santos. Lauren earned her Ph.D. in Biochemistry, Microbiology, and Molecular Biology from the Pennsylvania State University in 2017. She trained in the joint laboratory of Marty Bollinger, Jr. and Carsten Krebs, studying the mechanistic and functional diversity of non-heme diiron oxidases and oxygenases. Lauren did her postdoctoral training with Emily Balskus at Harvard University as a Merck fellow of the Helen Hay Whitney Foundation. Her research focused on dietary nutrient metabolism by the human gut microbiota linked to cardiovascular disease. She started her independent research group in the Department of Chemistry at the University of Washington in January 2022. The goal of her research program is to uncover the biochemical and molecular basis for host-microbe interactions, microbial community dynamics, and microbial environmental adaptation. We use protein biochemistry, microbiology, and bioinformatics to discover, characterize, and engineer microbial pathways and enzymes for applications in biocatalysis, bioremediation, and biomedical applications.

Biomarkers & Precision Medicine UK 2025

Biomarkers and Precision Medicine 2025 is an immersive event now in its 20th year, spotlighting the latest trends and tools in biomarker research. This year’s agenda also includes dedicated programmes on Spatial Biology for Precision Medicine and Digital Pathology & AI. The event gathers leading experts from global pharmaceutical companies, pioneering biotech firms & startups, and leading academic & healthcare institutions, all contributing to various therapeutic areas and stages of drug development, clinical trials, and precision patient treatments.

Daniela Matias de Carvalho Bittencourt

Dr. Daniela Matias de C. Bittencourt is a researcher at Embrapa Genetic Resources and Biotechnology and an adjunct researcher at the J. Craig Venter Institute. With over 17 years of experience at Embrapa, including four years in research and innovation management, she has led strategic projects in synthetic biology and advanced biotechnology for sustainable agriculture. Daniela has coordinated national R&D networks, managed research initiatives, and currently serves as a member of high-level advisory and portfolio management committees at Embrapa. Her work bridges cutting-edge science and public policy, with a strong focus on innovation, biosecurity, and the future of agriculture in the context of global challenges.

Ashty Karim

Ashty Karim is an assistant professor of Chemical and Biological Engineering at Northwestern University. With a foundation in chemical engineering and synthetic biology, he has worked in cell-free systems for >10 years at the intersection of biology and chemistry developing technologies to efficiently harness biological systems to convert waste to value. His research group develops biological molecules, systems, and processes to enable global sustainability, with a particular focus on increasing our ability to biorecover resources from waste, biorecycle waste materials, and biocapture waste carbon. He earned his B.S. degrees in Chemical Engineering and in Biology from the University of Texas at Austin and received his Ph.D. in Chemical Engineering from Northwestern University. Embracing the academic mission of developing both knowledge and people, Ashty has also spent the last several years co-developing new educational frameworks, courses, and workshops for learning and teaching synthetic biology.

Pavel Dvořák

Pavel Dvořák, Ph.D.
He is currently an associate professor at Masaryk University (MUNI), Brno, Czech Republic, and group leader at the Microbial Bioengineering Laboratory (MBL).

Pavel Dvořák is a molecular biologist by training. During his Ph.D. studies (completed in 2014), he worked in the protein engineering group of Jiri Damborsky (Loschmidt Laboratories) on the design of synthetic enzyme cascades for the degradation of halogenated anthropogenic pollutants in vitro and in heterologous bacterial hosts.

Pavel conducted his postdoctoral research (2015 – 2018) as a Marie S. Curie fellow in the laboratory of Víctor de Lorenzo at CNB-CSIC, Madrid, where he focused on microbial metabolic engineering and synthetic biology, working on the refactoring of Pseudomonas putida for the biotechnological processing of carbohydrates from lignocellulosic residues.

In 2019, Pavel established the MBL at MUNI, and since then, he has continued to push the boundaries of mesophilic and thermophilic environmental bacteria for biotechnology using tools of synthetic biology and metabolic engineering.

Pavel is involved in teaching, mentoring, science popularization, and local SynBio community building. He is one of the PIs of the successful Brno iGEM team, a member of the Bioengineering and Bioprocessing Division of the European Federation of Biotechnology, a member of the Early Career Committee of the International Metabolic Engineering Society (IMES), and an EUSynBioS Advisory Board member. He promotes engineering biology in the Czech Republic. He recently founded the web platform Czech SynBio Node, which aims to unite laboratories, companies, and other local partners interested in engineering biology.

Back to top ⇑